Top 28 Aimmune Therapeutics investors
The most complete profiles first. Showing 28 of 28.
Amar PatelVerified
Venture Capital, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Brian LiuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Jim TananbaumVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareBiotechnologyConsumer HealthElectronic Health Records (EHR)Portfolio: Element Biosciences, Peloton Therapeutics, Genomics, Keros Therapeutics and 8 more
Verified email available
Karthik BolisettyVerified
Venture Capital, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Michael WertVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Sonia ParekhVerified
Venture Capital, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Garrett HowardVerified
Venture Capital · United States
Health CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Josh RichardsonVerified
Venture Capital · United States
Health CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Maxwell Bikoff
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Carolyn Helms
Venture Capital, Private Equity Firm · United States
Health CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Contact details available
Marc
Venture Capital, Private Equity Firm · United States
Health CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Zander Liem
Venture Capital · United States
Health CareWearablesWomen FoundedLife SciencePortfolio: Zavante Therapeutics, CardioDx, WelbeHealth, Velicept Therapeutics and 52 more
Contact details available
Stacey SeltzerVerified
Venture Capital, Angel/Individual · United States
PharmaceuticalsPortfolio: Agile Therapeutics, Aimmune Therapeutics
Verified email available
Frequently asked questions
How many Aimmune Therapeutics investors are on Angel Roster?
Angel Roster lists 28 Aimmune Therapeutics investors. 20 of them (71%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (27), Private Equity Firms (21) and Angel Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Aimmune Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (15).
Where are Aimmune Therapeutics investors based?
Most are based in the United States (27) and the United Kingdom (1).
Which companies have Aimmune Therapeutics investors backed?
The most-backed portfolio companies among them are Esperion Therapeutics (19), Poseida Therapeutics (19), Talaris Therapeutics (19), Vaxcyte (18) and Verona Pharma (15).
How do I contact Aimmune Therapeutics investors?
Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.